NCT07210216

Brief Summary

This observational study aims to identify early diagnostic markers of glaucomatous damage by combining functional and structural assessments. Patients with primary open-angle glaucoma and ocular hypertension will undergo comprehensive ophthalmological evaluation, including visual field testing and multimodal imaging of the optic nerve and retina. Both retrospective and prospective data will be collected. The main objective is to define new diagnostic paradigms for detecting early glaucomatous changes and to improve the accuracy of current clinical practice in glaucoma management.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
25mo left

Started Oct 2025

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Oct 2025Jun 2028

First Submitted

Initial submission to the registry

September 29, 2025

Completed
2 days until next milestone

Study Start

First participant enrolled

October 1, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 7, 2025

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

October 7, 2025

Status Verified

September 1, 2025

Enrollment Period

2.2 years

First QC Date

September 29, 2025

Last Update Submit

September 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Prevalence of early glaucomatous damage detected by multimodal imaging

    Evaluation of structural parameters from OCT and OCTA and functional indices from visual field testing to detect early glaucomatous damage in ocular hypertensive and glaucoma patients.

    Baseline to 24 months

Secondary Outcomes (1)

  • Correlation between OCT structural parameters and visual field indices

    Baseline to 24 months

Eligibility Criteria

Age40 Years - 90 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (40-90 years) with primary open-angle glaucoma, ocular hypertension, or healthy controls, recruited at the Glaucoma Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS.

You may qualify if:

  • Age between 40 and 90 years.
  • Best-corrected visual acuity ≥ 0.1 LogMAR (≥ 8/10).
  • For primary open-angle glaucoma (POAG):
  • IOP ≥ 21 mmHg with normal visual field and/or normal optic nerve head/RNFL, or
  • Suspicious optic nerve head (excavation), or
  • Reproducible glaucomatous visual field defect.
  • POAG patients stratified by visual field mean deviation (MD): -3 to -10 dB (S1-S2 Brusini classification).

You may not qualify if:

  • Best-corrected visual acuity worse than 0.1 LogMAR (\< 8/10).
  • Ocular surgery in the last 6 months (except uncomplicated cataract extraction).
  • Previous vitreoretinal surgery for macular pathologies (e.g., macular pucker, macular hole) or retinal detachment.
  • High myopia (\> -3 diopters).
  • Optic disc anomalies not attributable to glaucoma (tilted disc, papillary drusen, other morphological/functional anomalies).
  • Severe motor disability preventing proper positioning for tests.
  • Cognitive impairment reducing test reliability.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Glaucoma, Open-AngleOcular Hypertension

Condition Hierarchy (Ancestors)

GlaucomaEye Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 29, 2025

First Posted

October 7, 2025

Study Start

October 1, 2025

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

June 1, 2028

Last Updated

October 7, 2025

Record last verified: 2025-09